BBIO
BridgeBio Pharma Inc
66.60$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | -625.2% | -4,845.6% | -714.2% | -540.3% | -5,672.6% | -234.7% | -88.8% | |
| – | – | 7.6% | 37.4% | 8.4% | 8.7% | 69.8% | 2.7% | 1.2% | |
| – | – | 52.7% | 708.7% | 142.7% | 117.9% | 1,236.3% | 43.2% | 26.5% | |
| – | – | 44.2% | 758.0% | 159.4% | 145.2% | – | – | – | |
| – | – | -26.9% | 181.0% | -6.3% | 36.2% | 54.4% | 14.4% | -10.2% | |
| – | – | 12.7% | 91.1% | 69.2% | 8.1% | 14.0% | 0.4% | 0.2% | |
| – | – | -535.6% | -642.4% | -288.1% | 583.6% | 580.8% | 27.4% | -4.9% | |
| – | – | 2.5% | 6,509.4% | 5.5% | – | – | – | – | |
| – | – | 909.6% | -917.9% | -293.7% | -2.0% | -74.0% | -3.4% | -9.6% | |
| – | – | 91.1% | 6,509.4% | 1,525.6% | -26.4% | 0.0% | 214.8% | 23.1% | |
| – | – | 983.2% | 5,421.1% | 1,056.4% | -16.9% | 4,853.6% | 337.3% | 71.6% | |
| – | – | -177.6% | -66.9% | 54.1% | 26.4% | -238.1% | 130.0% | -22.1% | |
| – | – | -637.9% | -4,936.7% | -783.4% | -548.4% | -5,686.6% | -235.1% | -89.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.